MedStartr vs Sofinnova: Revenue, Funding & Team Size Compared
MedStartr generates $12M in revenue; Sofinnova generates $11.8M. MedStartr and Sofinnova are close to the same size by revenue. The table below compares MedStartr and Sofinnova on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $12M | $11.8M |
| Funding raised | $50K | Not disclosed |
| Team size | 5 | 58 |
| Founded | 2012 | 1976 |
| HQ | New York, United States | Menlo Park, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
MedStartr at a glance
MedStartr generates $12M in revenue with 5 employees, headquartered in New York, United States.
- Revenue
- $12M
- Funding
- $50K
- Team size
- 5
- Founded
- 2012
MedStartr is a crowdfunding platform designed for the healthcare industry.
Sofinnova at a glance
Sofinnova generates $11.8M in revenue with 58 employees, headquartered in Menlo Park, United States.
- Revenue
- $11.8M
- Team size
- 58
- Founded
- 1976
Sofinnova is a clinical-stage biopharmaceutical venture capital firm, active in life science investing, primarily focusing on therapeutic drugs. The firm has approximately $3.3 billion in assets under management and is committed to…
Other MedStartr alternatives
MedStartr competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
MedStartr vs Sofinnova: frequently asked questions
Is MedStartr or Sofinnova bigger?
MedStartr is the bigger company by revenue, at $12M against $11.8M for Sofinnova.
How much revenue does MedStartr make?
MedStartr generates $12M in annual revenue with a team of 5.
How much revenue does Sofinnova make?
Sofinnova generates $11.8M in annual revenue with a team of 58.
How much funding has MedStartr raised?
MedStartr has raised $50K in total funding since it was founded in 2012.